128 results
Page 4 of 7
S-4
EX-10.54
lpnq63
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.16
lqu jxymug
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.45
7nq3d6q wpug78pv6
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.58
kzcsut g0z04bnzlw2wk
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.62
iwqeg
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.49
ova9iumq wy
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.64
35z0 he7kcn
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
8-K
EX-10.1
hk1vyp
4 Oct 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.2
uuh0b cu7iz2trb
1 Aug 19
Departure of Directors or Certain Officers
7:00am
8-K
EX-10.1
34hyfc0 r6xz505f
1 Aug 19
Departure of Directors or Certain Officers
7:00am
8-K
EX-10.1
4it4xy s21oedwq8r
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
8-K
EX-10.2
acq ltr6g6
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
8-K
EX-10.1
kuiwt
11 May 17
Conatus Announces Proposed Public Offering of Common Stock
12:00am